Literature DB >> 32241578

IgA nephropathy: A brief review.

Jared R Hassler1.   

Abstract

IgA nephropathy is a lifelong disease that is the most common primary glomerulopathy worldwide. It has a complicated and incompletely understood pathogenesis that is theorized as a four 'hit' process involving an improperly produced IgA. While it has a variety of histologic appearances, it is diagnosed by the presence of bright IgA deposits within the mesangium as seen on immunofluorescence and mesangial hypercellularity by light microscopy. This brief review explains the varied histologic features that are important in the diagnosis of IgA nephropathy and the calculation of the MEST-C score that was first introduced by the 2009 Oxford Classification working group.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Galactose-deficient IgA1; IgA nephropathy; MEST score; MEST-C score; Mesangial deposit; Oxford classification

Mesh:

Year:  2020        PMID: 32241578     DOI: 10.1053/j.semdp.2020.03.001

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  12 in total

1.  Plasma ST6GAL1 regulates IgG sialylation to control IgA nephropathy progression.

Authors:  Youxia Liu; Huyan Yu; Sijing Wu; Xia Yang; Congcong Cao; Fanghao Wang; Junya Jia; Tiekun Yan
Journal:  Ther Adv Chronic Dis       Date:  2021-10-11       Impact factor: 5.091

2.  Identification of blood-based key biomarker and immune infiltration in Immunoglobulin A nephropathy by comprehensive bioinformatics analysis and a cohort validation.

Authors:  Jie Xu; Xiahong Shen; Xing Wei; Jie Ding; Jiaojiao Yuan; Zhen Weng; Yang He
Journal:  J Transl Med       Date:  2022-03-29       Impact factor: 5.531

3.  Rhein Inhibits NF-κB Signaling Pathway to Alleviate Inflammatory Response and Oxidative Stress of Rats with Chronic Glomerulonephritis.

Authors:  Qian Chen; Hai Guo; JuanJuan Hu; Xiaofeng Zhao
Journal:  Appl Bionics Biomech       Date:  2022-04-13       Impact factor: 1.664

4.  The Diagnostic and Predictive Significance of Immune-Related Genes and Immune Characteristics in the Occurrence and Progression of IgA Nephropathy.

Authors:  Jian-Bo Qing; Wen-Zhu Song; Chang-Qun Li; Ya-Feng Li
Journal:  J Immunol Res       Date:  2022-04-28       Impact factor: 4.493

5.  Immunosuppressants or corticosteroids compared with supportive therapy: a systematic review and meta-analysis on the efficacy and safety for IgA nephropathy treatment.

Authors:  Qipu Feng; Ying Xiong; Juexi Wang; Li Feng
Journal:  Ann Transl Med       Date:  2022-03

Review 6.  The pathological and outcome characteristics of renal lesions in Crohn's disease.

Authors:  Zhihui Yang; Xiaochang Xu; Yejing Dong; Yimin Zhang
Journal:  BMC Nephrol       Date:  2022-07-18       Impact factor: 2.585

7.  Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.

Authors:  Peter Garred; Andrea J Tenner; Tom E Mollnes
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

8.  Co-occurrence of IgA nephropathy and IgG4-Tubulointersitial nephritis effectively treated with tacrolimus: a case report.

Authors:  Mi Tian; Junjun Luan; Congcong Jiao; Qing Chang; Jeffrey B Kopp; Hua Zhou
Journal:  BMC Nephrol       Date:  2021-08-12       Impact factor: 2.388

Review 9.  Immunoregulation by Artemisinin and Its Derivatives: A New Role for Old Antimalarial Drugs.

Authors:  Feifei Qiu; Junfeng Liu; Xiumei Mo; Huazhen Liu; Yuchao Chen; Zhenhua Dai
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 7.561

10.  The comprehensive analysis of clinical trials registration for IgA nephropathy therapy on ClinicalTrials.gov.

Authors:  Yan Cui; Ya-Ling Zhai; Yuan-Yuan Qi; Xin-Ran Liu; Ya-Fei Zhao; Fu Lv; Li-Pei Han; Zhan-Zheng Zhao
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.